Crosspoint Capital Strategies, LLC - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
Crosspoint Capital Strategies, LLC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2015$10,000
+42.9%
90
+25.0%
0.00%0.0%
Q1 2015$7,000
+40.0%
72
+4.3%
0.00%
+50.0%
Q4 2014$5,000690.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders